Generation of cancer vaccine immunogens derived from Oncofetal antigen (OFA/iLRP) using variable epitope libraries tested in an aggressive breast cancer model

Martínez-Cortés, Fernando; Servín-Blanco, Rodolfo; Domínguez-Romero, Allan Noé; Munguı́a, Maria Elena; Valle, Jesus Guzman; Odales, Josué; Gevorkian, Goar; Manoutcharian, Karen

doi:10.1016/j.molimm.2021.08.013

Molecular Immunology

2021

DOI: 10.1016/j.molimm.2021.08.013

|View full text |Cite

Generation of cancer vaccine immunogens derived from Oncofetal antigen (OFA/iLRP) using variable epitope libraries tested in an aggressive breast cancer model

Fernando Martínez-Cortés

Rodolfo Servín-Blanco

Allan Noé Domínguez-Romero

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

References 55 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Generation of cancer vaccine immunogens derived from Oncofetal antigen (OFA/iLRP) using variable epitope libraries tested in an aggressive breast cancer model

Cited by 5 publications

References 55 publications

Aluminum nanoparticles deliver a dual-epitope peptide for enhanced anti-tumor immunotherapy

Aluminum nanoparticles deliver a dual-epitope peptide for enhanced anti-tumor immunotherapy

Are we getting closer to a successful neoantigen cancer vaccine?

Tumor antigen-unbiased variable epitope library contains mimotopes with antitumor effect in a mouse model of breast cancer

Contact Info

Product

Resources

About